Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Gustavo A. Angarita, Hasti Hadizadeh, Ignacio Cerdena & Marc N. Potenza. (2021) Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?. Expert Opinion on Pharmacotherapy 22:13, pages 1669-1683.
Read now
Read now
Changsu Han, Sheng-Min Wang, Masaki Kato, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand & Chi-Un Pae. (2013) Second-generation antipsychotics in the treatment of major depressive disorder: current evidence. Expert Review of Neurotherapeutics 13:7, pages 851-870.
Read now
Read now
Danielle S Cha & Roger S McIntyre. (2012) Treatment-emergent adverse events associated with atypical antipsychotics. Expert Opinion on Pharmacotherapy 13:11, pages 1587-1598.
Read now
Read now
William V Bobo & Richard C Shelton. (2009) Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues. Neuropsychiatric Disease and Treatment 5, pages 369-383.
Read now
Read now
Articles from other publishers (6)
Noriyuki Konishi, Hajime Kumagai, Hiroyuki Sawatari, Tetsuro Hoshino, Yoko Murase, Maiko Yamaguchi, Ayako Urabe, Yuka Kiyohara, Aki Arita, Masayo Baku, Ryujiro Sasanabe & Toshiaki Shiomi. (2022) Efficacy of a Combination Therapy for Difficulties Waking Up in Non-School-Attending Students. Journal of Clinical Medicine 11:12, pages 3271.
Crossref
Crossref
Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch & Kevin W. Morin. (2022) Optimized Clinical Strategies for Treatment-Resistant Depression: Integrating Ketamine Protocols with Trauma- and Attachment-Informed Psychotherapy. Psych 4:1, pages 119-141.
Crossref
Crossref
Se-hoon Shim, Young Sup Woo, Ji Sun Kim, In Soo Heo, Hee-jung Yoon, Hyung Mo Sung, Jonghun Lee & Won-Myong Bahk. (2022) Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial. Clinical Psychopharmacology and Neuroscience 20:1, pages 143-153.
Crossref
Crossref
Małgorzata Jarończyk & Jarosław Walory. (2022) Novel Molecular Targets of Antidepressants. Molecules 27:2, pages 533.
Crossref
Crossref
Filippo Cantù, Giandomenico Schiena, Domenico Sciortino, Lorena Di Consoli, Giuseppe Delvecchio, Eleonora Maggioni & Paolo Brambilla. (2022) Use of 30-Hz Accelerated iTBS in Drug-Resistant Unipolar and Bipolar Depression in a Public Healthcare Setting: A Case Series. Frontiers in Psychiatry 12.
Crossref
Crossref
Katarzyna Bliźniewska-Kowalska, Bernadeta Szewczyk, Małgorzata Gałecka, Kuan-Pin Su, Michael Maes, Janusz Szemraj & Piotr Gałecki. (2020) Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?. Journal of Clinical Medicine 9:12, pages 4018.
Crossref
Crossref